Further stratifying participants by presence of absence of APOE ε4 allele (Fig. 5B), we found that PC1 and PC5 were protective of biological AD and clinical AD respectively, only in APOE ε4 non-carriers, whereas risk conferred by PC4 was restricted to APOE ε4 carriers. The gene discussed is APOE; the disease is Alzheimer disease.